Fabiola Franco Head of Business Development, Frontage Europe

Frontage Europe delivers integrated bioanalytical and central laboratory solutions to support preclinical and clinical development programs across the drug development lifecycle.

Operating from a 2,500-square-meter facility in Milan, we specialize in the bioanalysis of small and large molecules, the synthesis of radio- and isotope-labeled compounds, metabolite identification, and central laboratory services. Our state-of-the-art laboratory supports quantitative mass spectrometry, ligand-binding and biomarker assays, with in-house synthesis of stable-labeled internal standards to ensure accurate and reliable quantitative analysis. We also provide pharmacokinetic expertise and regulatory support, including IB and IND preparation.

Operating under GLP and GCP, and in compliance with ICH M10, we ensure high-quality assay validation and sample analysis through robust, SOP-driven processes. Our experienced team—averaging over 15 years of CRO and pharmaceutical experience—is committed to delivering reliable data, regulatory confidence, and scientific excellence.